Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,895 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01070706 | Phase Ib/II Study of Primary Chemotherapy With Paclitaxel, Gemcitabine, and Sunitinib(PGS) | completed | Phase 1 / Phase 2 | 15 | Jungsil RoOTHER_GOV | 1 | Jan 4, 2012 | clinicaltrials |
| NCT00760370 | Comparison of Zometa Retention and Effect in Multiple Myeloma and Breast Cancer | completed | Phase 2 | 60 | Vejle HospitalOTHER | 1 | Dec 7, 2011 | clinicaltrials |
| NCT00003887 | Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation | completed | Phase 2 | — | Fred Hutchinson Cancer CenterOTHER | 1 | Nov 30, 2011 | clinicaltrials |
| NCT00206505 | Neoadjuvant Taxotere | completed | Phase 2 | 40 | Baylor Breast Care CenterOTHER | 1 | Nov 17, 2011 | clinicaltrials |
| NCT00196820 | Mono Efficacy of Capecitabine (MoniCa) | completed | Phase 2 | 200 | GBG Forschungs GmbHOTHER | 1 | Oct 6, 2011 | clinicaltrials |
| NCT01439191 | Study of Cipterbin®, Used Alone or With Vinorelbine in Patients With HER2/Neu-overexpressed Metastatic Breast Cancer | completed | Phase 2 | 109 | Shanghai CP Guojian Pharmaceutical Co., Ltd.INDUSTRY | 1 | Sep 23, 2011 | clinicaltrials |
| NCT01423695 | Weekly Paclitaxel and Trastuzumab in Metastatic Breast Cancer | completed | Phase 2 | 121 | WiSP Wissenschaftlicher Service Pharma GmbHOTHER | 1 | Aug 26, 2011 | clinicaltrials |
| NCT01422551 | Facilitating Positive Adaptation to Breast Cancer | completed | Phase 2 | 240 | University of MiamiOTHER | 1 | Aug 24, 2011 | clinicaltrials |
| NCT00795899 | Taxol Epirubicin Cyclophosphamide Herceptin Neoadjuvant (TECHNO) | completed | Phase 2 | 230 | GBG Forschungs GmbHOTHER | 1 | Aug 16, 2011 | clinicaltrials |
| NCT00602108 | Radiation Therapy in Treating Women Undergoing Lumpectomy for Stage I or Stage IIA Breast Cancer | completed | Phase 2 | 50 | Mayo ClinicOTHER | 0 | Aug 10, 2011 | clinicaltrials |
| NCT00515762 | Prevention of Persistent Alopecia Following Docetaxel by Means of Scalp Cooling | completed | Phase 2 | 150 | Hospital San Carlos, MadridOTHER | 1 | Aug 9, 2011 | clinicaltrials |
| NCT00028639 | PS-341 in Treating Women With Metastatic Breast Cancer | completed | Phase 2 | — | Northwestern UniversityOTHER | 1 | Jul 29, 2011 | clinicaltrials |
| NCT00035841 | Phase 2 Study of TLK286 in Metastatic Breast Cancer | completed | Phase 2 | 60 | TelikINDUSTRY | 1 | Jul 25, 2011 | clinicaltrials |
| NCT00471276 | Efficacy And Safety Of Sunitinib In Women With Advanced Breast Cancer | completed | Phase 2 | 83 | PfizerINDUSTRY | 1 | Jul 25, 2011 | clinicaltrials |
| NCT00243503 | Open Label Study Of SU011248 In Combination With Trastuzumab For Patients With Metastatic Breast Cancer | completed | Phase 2 | 60 | PfizerINDUSTRY | 5 | Jul 22, 2011 | clinicaltrials |
| NCT00429247 | Randomized Trial With Trastuzumab Versus Observation in Breast Cancer Patients | completed | Phase 2 | 75 | University Hospital of CreteOTHER | 1 | Jul 21, 2011 | clinicaltrials |
| NCT00629148 | Sequential Versus Simultaneous Use of Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer (MBC) | completed | Phase 2 | 60 | Fudan UniversityOTHER | 1 | Jul 7, 2011 | clinicaltrials |
| NCT00601159 | Gemcitabine and Cisplatin as First Line Combination Therapy in Patients With Triple-negative MBC | completed | Phase 2 | 70 | Fudan UniversityOTHER | 1 | Jul 4, 2011 | clinicaltrials |
| NCT01206881 | Neoadjuvant Pegylated Liposomal Doxorubicin and Cyclophosphamide +/- Trastuzumab Followed by Docetaxel in Breast Cancer | completed | Phase 2 | 45 | Herlev HospitalOTHER | 1 | Jul 4, 2011 | clinicaltrials |
| NCT00524810 | Liposomal Doxorubicin and Docetaxel in Metastatic Breast Cancer | completed | Phase 2 | 67 | ARCAGY/ GINECO GROUPOTHER | 1 | Jun 30, 2011 | clinicaltrials |
| NCT00485979 | Treatment of Larotaxel/Docetaxel, +/- Trastuzumab, After Anthracycline-cyclophosphamide in Breast Cancer Patients(SATIN) | completed | Phase 2 | 330 | SanofiINDUSTRY | 8 | Jun 28, 2011 | clinicaltrials |
| NCT00532272 | Goserelin/Letrozole in Premenopausal Patients vs Letrozole Alone in Postmenopausal Patients With MBC | completed | Phase 2 | 78 | National Cancer Center, KoreaOTHER_GOV | 1 | Jun 27, 2011 | clinicaltrials |
| NCT00532623 | Phase II Study of Gemcitabine/Vinorelbine vs Sequential Gemcitabine Followed by Vinorelbine in Metastatic Breast Cancer | completed | Phase 2 | 82 | National Cancer Center, KoreaOTHER_GOV | 0 | Jun 27, 2011 | clinicaltrials |
| NCT00004085 | Radioimmunotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer | completed | Phase 1 / Phase 2 | 15 | Garden State Cancer Center at the Center for Molecular Medicine and ImmunologyOTHER | 1 | Jun 22, 2011 | clinicaltrials |
| NCT00505271 | Safety and Efficacy Study Using Rexin-G for Breast Cancer | completed | Phase 1 / Phase 2 | 20 | Epeius BiotechnologiesINDUSTRY | 1 | Jun 10, 2011 | clinicaltrials |
| NCT00976365 | Evaluation of the Safety and Efficacy of THL-P in Metastatic Breast Cancer | completed | Phase 2 | 60 | Taiwan THL Co.LTd.INDUSTRY | 1 | Jun 9, 2011 | clinicaltrials |
| NCT00110084 | ABI-007 (Nab-Paclitaxel) and Gemcitabine in Treating Women With Metastatic Breast Cancer | completed | Phase 2 | 50 | Mayo ClinicOTHER | 1 | Jun 2, 2011 | clinicaltrials |
| NCT00031278 | Safety And Efficacy Study Of The Combination Of CpG 7909 And Herceptin In Patients With Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 12 | PfizerINDUSTRY | 1 | May 30, 2011 | clinicaltrials |
| NCT00325234 | Pemetrexed-Carboplatin and Gemcitabine-Vinorelbine in Advanced Breast Cancer | completed | Phase 2 | 135 | Eli Lilly and CompanyINDUSTRY | 5 | May 20, 2011 | clinicaltrials |
| NCT00322517 | Study Of The Efficacy And Safety Of SU-014813 In Patients With Metastatic Breast Cancer | completed | Phase 2 | 90 | PfizerINDUSTRY | 5 | May 17, 2011 | clinicaltrials |
| NCT00645866 | Epirubicin, Docetaxel, and Capecitabine in Treating Women With Stage IIIA or Stage IIIB Breast Cancer | completed | Phase 2 | 47 | Mayo ClinicOTHER | 0 | May 16, 2011 | clinicaltrials |
| NCT00771433 | G-CSF in Preventing Neutropenia in Women Receiving Chemotherapy for Breast Cancer | completed | Phase 2 | 120 | Centre Francois BaclesseOTHER | 1 | May 13, 2011 | clinicaltrials |
| NCT00193076 | Combination Gemcitabine, Carboplatin With or Without Trastuzumab in Patients With Metastatic Breast Cancer | completed | Phase 2 | 96 | SCRI Development Innovations, LLCOTHER | 1 | May 3, 2011 | clinicaltrials |
| NCT00497809 | Safety and Efficacy Study of GCSF Therapy to Treat Patients at High Risk for Chemotherapy Induced Severe Neutropenia | completed | Phase 2 | 189 | AviGenicsINDUSTRY | 2 | May 3, 2011 | clinicaltrials |
| NCT00050427 | A Study of ET-743 (Trabectedin) in Patients With Advanced Breast Cancer | completed | Phase 2 | 53 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.INDUSTRY | 0 | Apr 28, 2011 | clinicaltrials |
| NCT00371345 | Study of Dasatinib (BMS-354825) in Patients With Advanced Estrogen/Progesterone Receptor-positive (ER+/PR+) or Her2/Neu-positive (Her2/Neu+)Breast Cancer | completed | Phase 2 | 92 | Bristol-Myers SquibbINDUSTRY | 7 | Apr 26, 2011 | clinicaltrials |
| NCT00174343 | Exemestane As Treatment In Neoadjuvant Setting For Operable Breast Cancer Patients | completed | Phase 2 | 46 | PfizerINDUSTRY | 1 | Apr 22, 2011 | clinicaltrials |
| NCT00062751 | Study Evaluating Temsirolimus (CCI-779) In Breast Neoplasms | completed | Phase 2 | 108 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 0 | Apr 15, 2011 | clinicaltrials |
| NCT00253539 | Arzoxifene or Tamoxifen in Preventing Breast Cancer in Premenopausal Women at High Risk for Breast Cancer | completed | Phase 2 | 3 | The Cleveland ClinicOTHER | 0 | Apr 13, 2011 | clinicaltrials |
| NCT00386685 | XRP9881 in Combination With Trastuzumab in Metastatic Breast Cancer | completed | Phase 2 | 51 | SanofiINDUSTRY | 4 | Apr 12, 2011 | clinicaltrials |
| NCT00006825 | Liposomal Doxorubicin and Trastuzumab in Treating Women With Advanced Breast Cancer | completed | Phase 1 / Phase 2 | — | NYU Langone HealthOTHER | 1 | Mar 28, 2011 | clinicaltrials |
| NCT00003035 | Doxorubicin and Paclitaxel in Treating Women With Locally Advanced Breast Cancer | completed | Phase 2 | 40 | Georgetown UniversityOTHER | 1 | Mar 24, 2011 | clinicaltrials |
| NCT00003125 | Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors | completed | Phase 2 | 24 | Georgetown UniversityOTHER | 1 | Mar 24, 2011 | clinicaltrials |
| NCT00669565 | Safety and Efficacy Study of Bavituximab Plus Paclitaxel and Carboplatin to Treat Breast Cancer | completed | Phase 2 | 46 | Peregrine PharmaceuticalsINDUSTRY | 1 | Mar 24, 2011 | clinicaltrials |
| NCT00967824 | Tamoxifen Citrate Decision Aids for Women at Increased Risk of Breast Cancer | completed | Phase 1 / Phase 2 | 1,683 | University of Michigan Rogel Cancer CenterOTHER | 0 | Mar 24, 2011 | clinicaltrials |
| NCT01112189 | Use of Stem Cells in Lymphedema Post Mastectomy(SCL) | completed | Phase 1 / Phase 2 | 20 | Hospital Universitario Dr. Jose E. GonzalezOTHER | 1 | Mar 24, 2011 | clinicaltrials |
| NCT00186524 | Do Community Cancer Support Groups Reduce Physiological Stress in Women With Primary Breast Cancer? | completed | Phase 2 | — | Stanford UniversityOTHER | 1 | Mar 15, 2011 | clinicaltrials |
| NCT00371254 | A Study of Dasatinib (BMS-354825) in Patients With Advanced 'Triple-negative' Breast Cancer | completed | Phase 2 | 55 | Bristol-Myers SquibbINDUSTRY | 4 | Mar 15, 2011 | clinicaltrials |
| NCT00433095 | Vinorelbine (Oral) Plus Trastuzumab for 1st-line Treatment of HER2/Neu Overexpressing Breast Cancer | completed | Phase 2 | — | Ludwig-Maximilians - University of MunichOTHER | 1 | Mar 14, 2011 | clinicaltrials |
| NCT00003877 | Peripheral Stem Cell Transplantation With or Without Stromagen Following Chemotherapy in Treating Women With Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 30 | Roswell Park Cancer InstituteOTHER | 1 | Mar 7, 2011 | clinicaltrials |
Data updated 23 days agoSource updated Jan 4, 2012source: clinicaltrials